Activation of the nuclear factor-kappa B- (NF-κB-) signaling pathway can target genes associated with tumor progression and up-regulate expression of tumor-promoting cytokines and survival genes in tumors [77]. The gene discussed is NFKB1; the disease is neoplasm.